The Cigna Groupvs.McKesson
CI vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 1.4× larger than The Cigna Group by market cap; The Cigna Group trades at the lower P/E (11.5 vs 21.9); year to date, McKesson leads (+6.5% vs +1.9%).
Side by side
| CI | MCK | |
|---|---|---|
| Market cap | $73.9B | $101B |
| Price | $279.32 | $905.09 |
| Today | −0.4% | +3.6% |
| Return YTD | +1.9% | +6.5% |
| Return 1Y | −7.9% | +26.7% |
| P/E | 11.5 | 21.9 |
| P/S | 0.3 | 0.2 |
| P/B | 1.7 | 17.1 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
The Cigna GroupCI
Express Scripts, the pharmacy benefit manager, sits at the centre. Around it Cigna writes health insurance and runs a specialty pharmacy and distribution business.
Full CI profile →McKessonMCK
Medicines reach the counter through wholesalers, and McKesson is one of them: its customers run from pharmacies to hospitals and clinics across the US. Alongside distribution it sells services to pharmacy operators and runs an oncology network.
Full MCK profile →More CI & MCK comparisons
Other head-to-heads in the Distribution & pharmacy infrastructure segment.